长波紫外线1皮肤科临床应用专家共识(2022)  

Clinical application of ultraviolet A1 in dermatology: an expert consensus statement (2022)

作　　者：中国研究型医院学会皮肤科学专业委员会 中国医师协会皮肤科医师分会 顾恒 陈崑 Dermatology Professional Committee of Chinese Research Hospital Society;China Dermatologist Association;Gu Heng;Chen Kun

机构地区：[1]不详 [2]中国医学科学院皮肤病医院

出　　处：《中华皮肤科杂志》2022年第11期956-961,共6页Chinese Journal of Dermatology

摘　　要：长波紫外线1(UVA1)在皮肤疾病治疗中已有较广泛的应用,与传统的UVA加补骨脂素(PUVA)以及中波紫外线光疗法相比,UVA1不仅穿透较深,而且无PUVA相关光毒反应等不良反应,为局限性硬皮病、特应性皮炎及蕈样肉芽肿等提供了新的治疗方法。为保障UVA1光疗的有效性及安全性,相关领域专家基于国内外临床研究数据及临床经验,在充分讨论后拟定本共识,从UVA1光谱特性及作用机制、适应证及禁忌证、治疗方案、常见不良反应与处理等方面阐述,为皮肤科临床医师提供指导意见。Ultraviolet A1(UVA1)has been proven to be useful in the treatment of a lot of dermatoses.UVA1 not only has stronger penetrativity than ultraviolet B(UVB)does,but also has no adverse effects such as phototoxic reactions compared with psoralen plus ultraviolet A radiation(PUVA),which provides a new therapy for localized scleroderma,atopic dermatitis,mycosis fungoides,etc.In order to ensure the efficacy and safety of UVA1 phototherapy,relevant experts developed this consensus after full discussions based on clinical research data and experience.The consensus elaborates on the spectral characteristics,mechanisms of action,indications and contraindications,treatment regimens of,as well as adverse reactions induced by UVA1 phototherapy,providing guidance for dermatologists in clinical practice.

关 键 词：紫外线疗法 皮肤疾病 治疗应用 硬皮病 局部性 皮炎 特应性 蕈样肉芽肿 UVA1 专家共识 

分 类 号：R751.05[医药卫生—皮肤病学与性病学]